Tumor Necrosis Factor-α Promoter Polymorphisms in Mexican Patients With Spondyloarthritis

Human Immunology

Volumn 67, Issue 10, 2006, Pages 826-832

  Vargas Alarcón, Gilberto ^a   Casasola Vargas, Julio ^b   Rodríguez Pérez, José Manuel ^a   Huerta Sil, Gabriela ^b   Pérez Hernández, Nonanzit ^a   Londoño, John ^c   Pacheco Tena, Cesar ^d   Cardiel, Mario H ^e   Granados, Julio ^f   Burgos Vargas, Rubén ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c UNIVERSIDAD DE LA SABANA   (Colombia)

^d UNIVERSIDAD AUTÓNOMA DE CHIHUAHUA   (Mexico)

^e HOSPITAL GENERAL DR MIGUEL SILVA   (Mexico)

^f INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Ankylosing spondylitis; genetic susceptibility; polymorphisms; spondyloarthritis; tumor necrosis factor alpha

Indexed keywords

HLA B27 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REACTIVE ARTHRITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ARTHRITIS, REACTIVE; FEMALE; GENE FREQUENCY; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; MALE; MEXICO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750006798     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.07.009     Document Type: Article

References (35)

1. Wordsworth P., and Brown M. HLA-B27, ankylosing spondylitis and the spondyloarthritis. In: Calin A., and Taurog J.D. (Eds). The spondyloarthritides 1998 (1998), Oxford University Press, Oxford 179-193
2. Khan M.A. An overview of clinical spectrum and heterogeneity of spondyloarthropathies. Rheum Dis Clin North Am 18 (1992) 1
3. Khan M.A., and Kellner H. Immunogenetics of spondyloarthritis. Rheum Dis Clin North Am 18 (1992) 837
4. Van der Linden S.M., Valkenburg H.A., de Jongh B.M., and Cats A. The risk of developing ankylosing spondylitis in HLA-B27-positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27 (1984) 241
5. Braun J., Bollow M., Remlinger G., Eggens U., Rudwaleit M., Distler A., and Sieper J. Prevalence of spondyloarthritis in HLA-B27-positive and negative blood donors. Arthritis Rheum 41 (1998) 58
6. Rudle N.H. Tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β). Curr Opin Immunol 4 (1992) 327
7. Höhler T., Schäper T., Schneider P.M., Meyer zum Buschenfelde K.H., and Marker-Hermann E. Association of different tumor necrosis factor α promoter allele frequencies with ankylosing spondylitis in HLA-B27-positive individuals. Arthritis Rheum 41 (1998) 1489
8. Vinasco J., Beraun Y., Nieto A., Fraile A., Mataran L., Pareja E., and Martin J. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 49 (1997) 74
9. Brinkman B.M., Huizinga T.W., Kurban S.S., van der Velde E.A., Schreuder G.M., Hazes J.M., Breedveld F.C., and Verweij C.L. Tumor necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?. Br J Rheumatol 36 (1997) 516
10. Wilson A.G., Gordon C., and di Giovine F.S. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 24 (1994) 191
11. Zuñiga J., Vargas-Alarcón G., Hernández-Pacheco G., Portal-Celhay C., Yamamoto-Furusho J.K., and Granados J. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2 (2001) 363
12. Spies T., Morton C.C., Nedospasov S.A., Fiers W., Pious D., and Strominger J.L. Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 83 (1986) 8699
13. D'alfonso S., and Richardi P.M. A polymorphic variation in a putative regulation box of the TNF alpha promoter region. Immunogenetics 39 (1994) 150
14. Wilson A.G., di Giovine F.S., Blakemore A.I.F., and Duff G.W. Single base polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94 (1997) 3195
15. Kroeger K.M., Carville K.S., and Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34 (1997) 391
16. Wilson A.G., de Vries N., Pociot G., di Giovine F.S., van der Putte L.B.A., and Duff G.W. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 177 (1993) 557
17. Vargas-Alarcon G., Londono J.D., Hernandez-Pacheco G., Pacheco-Tena C., Castillo E., Cardiel M.H., Granados J., and Burgos-Vargas R. The effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthritis in Mexican patients. Ann Rheum Dis 61 (2002) 714
18. Vargas-Alarcon G., Londono J.D., Hernandez-Pacheco G., Gamboa R., Castillo E., Pacheco-Tena C., Cardiel M.H., Granados J., and Burgos-Vargas R. Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthritis. Ann Rheum Dis 61 (2002) 48
19. Vargas-Alarcon G., Gamboa R., Zuniga J., Fragoso J.M., Hernandez-Pacheco G., Londono J., Pacheco-Tena C., Cardiel M.H., Granados J., and Burgos-Vargas R. Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 65 (2004) 1437
20. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., Cats A., Dijkmans B., Olivieri I., and Pasero G. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34 (1991) 1218
21. Bennett P.H., and Burch T.A. New York symposium on population studies in the rheumatic diseases: new diagnostic criteria. Bull Rheum Dis 17 (1967) 453
22. Kingsley G., and Sieper J. Third international workshop on reactive arthritis. An overview. Ann Rheum Dis 55 (1996) 564
23. Cardiel M.H., Londoño J.D., Gutiérrez E., Pacheco-Tena C., Vázquez-Mellado J., and Burgos-Vargas R. Translation, cross cultural adaptation, and validation of the Bath ankylosing spondylitis functional index (BASFI) and the Dougados functional index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 21 (2003) 451
24. Garrett S.M., Jenkinson T., Kennedy L.G., Whitelock H., Gaisford P., and Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21 (1994) 2286
25. Calin A., Garrett S., Whitelock H., Kennedy L.G., O'Hea J., Mallorie P., and Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21 (1994) 2281
26. Davis R.W., Thomas M., Cameron J., St John T.P., and Padgett R.A. Rapid DNA isolation for enzymatic and hybridization analysis. Methods Enzymol 65 (1980) 404
27. Skoog T., van't Hooft F.M., Kallin B., Jovinge S., Boquist S., Nilsson J., Eriksson P., and Hamsten A. A common functional polymorphism (C-A substitution at position -863) in the promoter region of the tumor necrosis factor-alpha (TNF-α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 8 (1999) 1443
28. Wilson A.G., di Giovine F.S., Blakemore A.I., and Duff G.W. Single base polymorphism in the human tumor necrosis factor alpha (TNFalpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1 (1992) 353
29. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 19 (1955) 251
30. McGarry F., Walker R., Sturrock R.D., and Field M. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol 26 (1999) 1110
31. Verjans G.M., Brinkman B.M., Van Doornik C.E., Kijlstra A., and Verweij C.L. Polymorphism of tumor necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 97 (1994) 45
32. Fraile A., Nieto A., Beraún Y., Vinasco J., Matarán L., and Martín J. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens 51 (1998) 386
33. Milicic A., Lindheimer F., Laval S., Rudwaleit M., Ackerman H., Wordsworth P., Hohler T., and Brown M.A. Interethnic studies of TNF polymorphisms confirms the likely presence of a second MHC susceptibility locus in ankylosing spondylitis. Genes Immun 1 (2000) 418
34. Allen R.D. Polymorphism of the human TNF-alpha promoter-random variation or functional diversity. Mol Immunol 36 (1999) 1017
35. Seitz M, Wirthmuller U, Moller B, Villiger PM. The -308 tumor necrosis factor-{alpha} gene polymorphism predicts therapeutic response to TNF{alpha}-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (in press).